Cargando…
Carbamylated lipoproteins in diabetes
Diabetic dyslipidemia is characterized by quantitative and qualitative abnor-malities in lipoproteins. In addition to glycation and oxidation, carbamylation is also a post-translational modification affecting lipoproteins in diabetes. Patients with type 2 diabetes (T2D) exhibit higher levels of carb...
Autor principal: | Denimal, Damien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075031/ https://www.ncbi.nlm.nih.gov/pubmed/37035232 http://dx.doi.org/10.4239/wjd.v14.i3.159 |
Ejemplares similares
-
HDL functionality in type 1 diabetes: enhancement of cholesterol efflux capacity in relationship with decreased HDL carbamylation after improvement of glycemic control
por: Denimal, Damien, et al.
Publicado: (2022) -
The effect of carbamylation on the functionality of high-density lipoprotein
por: Holzer, Michael, et al.
Publicado: (2009) -
Association of carbamylated high-density lipoprotein with coronary artery disease in type 2 diabetes mellitus: carbamylated high-density lipoprotein of patients promotes monocyte adhesion
por: Chen, Zhongli, et al.
Publicado: (2020) -
High-Density Lipoprotein Alterations in Type 2 Diabetes and Obesity
por: Denimal, Damien, et al.
Publicado: (2023) -
Evalution of In Vitro Effect of Flavonoids on Human Low-Density Lipoprotein Carbamylation
por: Ghaffari, Mohammad Ali, et al.
Publicado: (2010)